240 related articles for article (PubMed ID: 10941248)
1. [Economic evaluation in oncology].
Schöffski O
Med Klin (Munich); 2000 Jun; 95 Suppl 1():14-7. PubMed ID: 10941248
[TBL] [Abstract][Full Text] [Related]
2. [Methodology of economic assessment: example in oncology].
Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
[TBL] [Abstract][Full Text] [Related]
3. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low E;
J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
[No Abstract] [Full Text] [Related]
4. [Benefit-risk evaluation of new drugs as a basis for decisions on prioritization in hematology/oncology: methodical challenges and problem-solving strategies].
Ludwig WD; Schildmann J
Onkologie; 2011; 34 Suppl 1():6-10. PubMed ID: 21389762
[TBL] [Abstract][Full Text] [Related]
5. United healthcare, five oncology practices try bundled payments.
Goozner M
J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
[No Abstract] [Full Text] [Related]
6. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of cancer therapy from the perspective of a statutory health insurance].
Rebscher H; Schellhammer S; Kopp T; Scharnetzky E
Urologe A; 2011 Dec; 50(12):1584-90. PubMed ID: 22159704
[TBL] [Abstract][Full Text] [Related]
8. Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands.
Franken MG; van Gils CW; Gaultney JG; Delwel GO; Goettsch W; Huijgens PC; Steenhoek A; Punt CJ; Koopman M; Redekop WK; Uyl-de Groot CA
Eur J Cancer; 2013 Jan; 49(1):8-16. PubMed ID: 22809557
[TBL] [Abstract][Full Text] [Related]
9. Managing oncology agents: an HMO's perspective.
Jaramillo R
Manag Care; 2007 Mar; 16(3 Suppl 4):16-8; discussion 18-9. PubMed ID: 18575218
[TBL] [Abstract][Full Text] [Related]
10. [Methodology of pharmacoeconomic studies in oncology].
Ballatori E
Recenti Prog Med; 2008 Jan; 99(1):42-7. PubMed ID: 18389873
[TBL] [Abstract][Full Text] [Related]
11. Oncological resource allocation in Germany.
Hartmann M; Kath R; Gundermann C
Onkologie; 2008 Mar; 31(3):85-9. PubMed ID: 18322410
[TBL] [Abstract][Full Text] [Related]
12. [Cancer and health economics].
Koinuma N
Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457
[TBL] [Abstract][Full Text] [Related]
13. European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF; Mason AR
J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
[TBL] [Abstract][Full Text] [Related]
14. Targeted immunotherapies overtaking emerging oncology market value based growth.
Jakovljevic MB
J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
[No Abstract] [Full Text] [Related]
15. [Oncology caught between economics and efficiency].
Keil TU
Med Klin (Munich); 2000 Jun; 95 Suppl 1():1. PubMed ID: 10941245
[No Abstract] [Full Text] [Related]
16. Interpreting the economic literature in oncology.
Grusenmeyer PA; Wong YN
J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
[TBL] [Abstract][Full Text] [Related]
17. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
18. [Economic effects of "molecular" medicine].
Riemann JF
Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
[No Abstract] [Full Text] [Related]
19. Communicating with patients about chemotherapy costs.
de Lemos ML
J Clin Oncol; 2007 May; 25(15):2142; author reply 2142. PubMed ID: 17513825
[No Abstract] [Full Text] [Related]
20. Financial relationships in economic analyses of targeted therapies in oncology.
Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
J Clin Oncol; 2012 Apr; 30(12):1316-20. PubMed ID: 22430267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
